Details for Patent: 8,545,879
✉ Email this page to a colleague
Which drugs does patent 8,545,879 protect, and when does it expire?
Patent 8,545,879 protects QMIIZ ODT and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 8,545,879
| Title: | Fast disintegrating compositions of meloxicam |
| Abstract: | The invention provides pharmaceutical compositions comprising a therapeutically effective amount of meloxicam, or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical compositions are in the form of a fast disintegrating dosage form suitable for releasing meloxicam rapidly in the oral cavity. Also provided are processes for preparing a pharmaceutical composition of the invention. Further provided are methods of treating arthritis or pain in a subject in need thereof, the method comprising orally administering to the subject a therapeutically effective amount of a pharmaceutical composition according to the invention. |
| Inventor(s): | Burns; David Allen (Wilmington, NC), Neal; Gregory Edward (Swindon, GB) |
| Assignee: | Wilmington Pharmaceuticals, LLC (Wilmington, NC) R.P. Scherer Techonologies, Inc. (Somerset, NJ) |
| Application Number: | 12/988,919 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 8,545,879
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera | QMIIZ ODT | meloxicam | TABLET, ORALLY DISINTEGRATING;ORAL | 211210-001 | Oct 19, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Tersera | QMIIZ ODT | meloxicam | TABLET, ORALLY DISINTEGRATING;ORAL | 211210-002 | Oct 19, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,545,879
| PCT Information | |||
| PCT Filed | August 31, 2010 | PCT Application Number: | PCT/US2010/047254 |
| PCT Publication Date: | March 03, 2011 | PCT Publication Number: | WO2011/026080 |
International Family Members for US Patent 8,545,879
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011026080 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
